Key Market Indicators
Sales of hypnotic and sedative medicines in Norway are projected to reach $43.21 million by 2026. This represents a 1.7% annual growth since 2021, when the country was in eighth place with sales of $39.27 million. Since 2007, the Norwegian market has increased 5.4% annually on average. Chile was ahead of Norway in 2021, with sales of $39.27 million. Germany, Sweden, and Belgium were numbers 2, 3, and 4, respectively, in this ranking.